# Oral microbiome and Porphyromonas gingivalis

The oral microbiome is the community of roughly 700 bacterial types in your mouth. They live on your teeth, gums, tongue, and lining. One species stands out: Porphyromonas gingivalis, a Gram-negative anaerobe. It is widely described as a 'keystone pathogen' of gum disease (periodontitis). Even in small amounts, it can drive dysbiosis and chronic inflammation. And the effects reach beyond your mouth. Periodontitis has been linked to heart disease, type 2 diabetes, and pregnancy complications. In 2019, Dominy and colleagues made a striking report. They found P. gingivalis DNA, and its 'gingipain' enzymes, in the brains of deceased Alzheimer's patients. Gingipain levels correlated with tau and ubiquitin pathology. And drugs that block gingipains reduced the bacteria and brain inflammation in mice. But the follow-up trial disappointed. The Phase 2/3 GAIN trial of a gingipain inhibitor (atuzaginstat, COR388) missed its co-primary endpoints in October 2021. The FDA put it on full clinical hold for liver toxicity in January 2022. And the final readout was negative in early 2022. So cause-and-effect in humans is unproven. Still, the work boosted interest in oral health as a modifiable, body-wide exposure.

## Sources

- Dominy SS, Lynch C, Ermini F, et al.. (2019). Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances. https://doi.org/10.1126/sciadv.aau3333
- Deo PN, Deshmukh R. (2019). Oral microbiome: unveiling the fundamentals. Journal of Oral and Maxillofacial Pathology. https://doi.org/10.4103/jomfp.JOMFP_304_18
- Liu S, Butler CA, Ayton S, Reynolds EC, Dashper SG. (2024). Porphyromonas gingivalis and the pathogenesis of Alzheimer's disease. Critical Reviews in Microbiology. https://doi.org/10.1080/1040841X.2022.2163613

---

_Canonical: https://usa-longevity.com/en/glossary/oral-microbiome · Part of Longevity Cities · Updated 2026-06-22_